VeroVaccines raises €1.6M Bridge round
25 February 2025· Halle (Saale), Germany· health, biotech, b2b, deep_hardware
The funds will be used to specifically further expand the company's product pipeline and push ahead with the development of vaccines for its own pipeline following the rapid development of a Bluetongue virus vaccine
Investors
LeadHigh-Tech Gründerfonds
Also participating
Bamac GmbHHanjo HennemannSven-Erik BehrensMartina Behrens
About VeroVaccines
Stage
Bridge
Headquarters
Halle (Saale), Germany
Founded
2021
Team Size
6–20
Sectors
healthbiotechb2bdeep_hardware